Shb null allele is inherited with a transmission ratio distortion and causes reduced viability in utero

Developmental Dynamics

Volumn 236, Issue 9, 2007, Pages 2485-2492

  Kriz, Vitezslav ^a,c   Mares, Jaroslav ^b   Wentzel, Parri ^a   Funa, Nina S ^a   Calounova, Gabriela ^a   Zhang, Xiao Qun ^a   Forsberg Nilsson, Karin ^a   Forsberg, Maud ^a   Welsh, Michael ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b CHARLES UNIVERSITY   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Knockout; Malformations; Ovulation; SHB; Transmission ratio distortion; Viability in utero

Indexed keywords

PROTEIN SH2; PROTEIN SHB; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLASTOCYST; CONGENITAL MALFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE; GENE FREQUENCY; GENE INACTIVATION; GENETIC ASSOCIATION; HETEROZYGOTE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; NULL ALLELE; OOCYTE; OVULATION; PRIORITY JOURNAL; REPRODUCTION; SHB GENE;

ABNORMALITIES, MULTIPLE; ALLELES; ANIMALS; BLASTOCYST; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HETEROZYGOTE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, GENETIC; OVULATION; PROTO-ONCOGENE PROTEINS;

ANIMALIA; MUS;

EID: 34548860663     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21257     Document Type: Article

References (30)

1. Arman E, Haffner-Krausz R, Chen Y, Heath JK, Lonai P. 1998. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc Natl Acad Sci U S A 95:5082-5087.
2. Bauer H, Willert J, Koschorz B, Herrmann BG. 2005. The t complex-encoded GTPase-activating protein Tagap1 acts as a transmission ratio distorter in mice. Nat Genet 37:969-973.
3. Cross MJ, Lu L, Magnusson P, Nyqvist D, Holmqvist K, Welsh M, Claesson-Welsh L. 2002. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells. Mol Biol Cell 13:2881-2893.
4. Cujec TP, Medeiros PF, Hammond P, Rise C, Kreider BL. 2002. Selection of v-abl tyrosine kinase substrate sequences from randomized peptide and cellular proteomic libraries using mRNA display. Chem Biol 9:253-264.
5. Dixelius J, Larsson H, Sasaki T, Holmqvist K, Lu L, Engstrom A, Timpl R, Welsh M, Claesson-Welsh L. 2000. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 95:3403-3411.
6. Holmqvist K, Cross MJ, Rolny C, Hagerkvist R, Rahimi N, Matsumoto T, Claesson-Welsh L, Welsh M. 2004. The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J Biol Chem 279:22267-22275.
7. Karlsson T, Welsh M. 1996. Apoptosis of NIH3T3 cells overexpressing the Src homology 2 domain protein Shb. Oncogene 13:955-961.
8. Karlsson T, Songyang Z, Landgren E, Lavergne C, Di Fiore PP, Anafi M, Pawson T, Cantley LC, Claesson-Welsh L, Welsh M. 1995. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins. Oncogene 10:1475-1483.
9. Kriz V, Anneren C, Lai C, Karlsson J, Mares J, Welsh M. 2003. The SHB adapter protein is required for efficient multilineage differentiation of mouse embryonic stem cells. Exp Cell Res 286: 40-56.
10. Kriz V, Agren N, Lindholm CK, Lenell S, Saldeen J, Mares J, Welsh M. 2006. The SHB adapter protein is required for normal maturation of mesoderm during in vitro differentiation of embryonic stem cells. J Biol Chem 281:34484-34491.
11. Lewandoski M, Wassarman KM, Martin GR. 1997. Zp3-cre, a transgenic mouse line for the activation or inactivation of loxP-flanked target genes specifically in the female germ line. Curr Biol 7:148-151.
12. Li R, Chase M, Jung SK, Smith PJ, Loeken MR. 2005. Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab 289:E591-E599.
13. Lindholm CK. 2002. IL-2 receptor signaling through the Shb adapter protein in T and NK cells. Biochem Biophys Res Commun 296:929-936.
14. Lindholm CK, Gylfe E, Zhang W, Samelson LE, Welsh M. 1999. Requirement of the Src homology 2 domain protein Shb for T cell receptor-dependent activation of the interleukin-2 gene nuclear factor for activation of T cells element in Jurkat T cells. J Biol Chem 274:28050-28057.
15. Lindholm CK, Frantz JD, Shoelson SE, Welsh M. 2000. Shf, a Shb-like adapter protein, is involved in PDGF-alpha-receptor regulation of apoptosis. Biochem Biophys Res Commun 278:537-543.
16. Lindholm CK, Henriksson ML, Hallberg B, Welsh M. 2002. Shb links SLP-76 and Vav with the CD3 complex in Jurkat T cells. Eur J Biochem 269:3279-3288.
17. Lu L, Anneren C, Reedquist KA, Bos JL, Welsh M. 2000. NGF-Dependent neurite outgrowth in PC12 cells overexpressing the Src homology 2-domain protein shb requires activation of the Rap1 pathway. Exp Cell Res 259:370-377.
18. Lu L, Holmqvist K, Cross M, Welsh M. 2002. Role of the Src homology 2 domain-containing protein Shb in murine brain endothelial cell proliferation and differentiation. Cell Growth Differ 13:141-148.
19. Lyon MF. 2005. Elucidating mouse transmission ratio distortion. Nat Genet 37: 924-925.
20. Oda T, Kujovich J, Reis M, Newman B, Druker BJ. 1997. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase. Oncogene 15:1255-1262.
21. Rolny C, Lu L, Agren N, Nilsson I, Roe C, Webb GC, Welsh M. 2005. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling. Exp Cell Res 308:381-393.
22. Sulik KK. 2005. Genesis of alcohol-induced craniofacial dysmorphism. Exp Biol Med (Maywood) 230:366-375.
23. Welsh M, Mares J, Karlsson T, Lavergne C, Breant B, Claesson-Welsh L. 1994. Shb is a ubiquitously expressed Src homology 2 protein. Oncogene 9:19-27.
24. Welsh M, Songyang Z, Frantz JD, Trub T, Reedquist KA, Karlsson T, Miyazaki M, Cantley LC, Band H, Shoelson SE. 1998. Stimulation through the T cell receptor leads to interactions between SHB and several signaling proteins. Oncogene 16: 891-901.
25. Welsh M, Christmansson L, Karlsson T, Sandler S, Welsh N. 1999. Transgenic mice expressing Shb adaptor protein under the control of rat insulin promoter exhibit altered viability of pancreatic islet cells. Mol Med 5:169-180.
26. Wentzel P, Eriksson UJ. 2006. Ethanol-induced fetal dysmorphogenesis in the mouse is diminished by high antioxidative capacity of the mother. Toxicol Sci 92:416-422.
27. Wentzel P, Gareskog M, Eriksson UJ. 2005. Folic acid supplementation diminishes diabetes- and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes 54:546-553.
28. Wentzel P, Rydberg U, Eriksson UJ. 2006. Antioxidative treatment diminishes ethanol-induced congenital malformations in the rat. Alcohol Clin Exp Res 30:1752-1760.
29. Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, Hicks C, Gendron-Maguire M, Rand EB, Weinmaster G, Gridley T. 1999. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 8:723-730.
30. Yanagi S, Inatome R, Ding J, Kitaguchi H, Tybulewicz VL, Yamamura H. 2001. Syk expression in endothelial cells and their morphologic defects in embryonic Syk-deficient mice. Blood 98:2869-2871.